Stock Track | Oscar Health Plunges 15.77% as Q4 Earnings Miss Estimates, FY25 Revenue Guidance Disappoints

Stock Track

Feb 05

Oscar Health, Inc. (OSCR) stock plummeted 15.77% in Tuesday's trading session after the health insurer reported worse-than-expected fourth quarter earnings results and provided underwhelming full-year 2025 revenue guidance.

For the fourth quarter of 2024, Oscar Health posted an earnings per share loss of $0.62, wider than the consensus analyst estimate of $0.58 per share. The company's revenue for the quarter came in at $2.39 billion, missing expectations of $2.47 billion. Higher medical costs were cited as a key factor behind the earnings miss.

Looking ahead, Oscar Health's full-year 2025 revenue guidance of $11.2-11.3 billion fell short of the consensus estimate of $11.69 billion, raising concerns among investors about the company's growth prospects. The disappointing guidance overshadowed the company's forecast for a return to profitability in 2025, with expected earnings from operations between $225-275 million.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1176108189"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1176108189\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1176108189?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-05 09:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176108189","market":"us","top_or_hot":-1,"title":"Stock Track | Oscar Health Plunges 15.77% as Q4 Earnings Miss Estimates, FY25 Revenue Guidance Disappoints","media":"Stock Track","content":"<p>Oscar Health, Inc. (OSCR) stock plummeted 15.77% in Tuesday's trading session after the health insurer reported worse-than-expected fourth quarter earnings results and provided underwhelming full-year 2025 revenue guidance.</p>\n\n<p>For the fourth quarter of 2024, Oscar Health posted an earnings per share loss of $0.62, wider than the consensus analyst estimate of $0.58 per share. The company's revenue for the quarter came in at $2.39 billion, missing expectations of $2.47 billion. Higher medical costs were cited as a key factor behind the earnings miss.</p>\n\n<p>Looking ahead, Oscar Health's full-year 2025 revenue guidance of $11.2-11.3 billion fell short of the consensus estimate of $11.69 billion, raising concerns among investors about the company's growth prospects. The disappointing guidance overshadowed the company's forecast for a return to profitability in 2025, with expected earnings from operations between $225-275 million.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Oscar Health Plunges 15.77% as Q4 Earnings Miss Estimates, FY25 Revenue Guidance Disappoints</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Oscar Health Plunges 15.77% as Q4 Earnings Miss Estimates, FY25 Revenue Guidance Disappoints\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-05 09:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Oscar Health, Inc. (OSCR) stock plummeted 15.77% in Tuesday's trading session after the health insurer reported worse-than-expected fourth quarter earnings results and provided underwhelming full-year 2025 revenue guidance.</p>\n\n<p>For the fourth quarter of 2024, Oscar Health posted an earnings per share loss of $0.62, wider than the consensus analyst estimate of $0.58 per share. The company's revenue for the quarter came in at $2.39 billion, missing expectations of $2.47 billion. Higher medical costs were cited as a key factor behind the earnings miss.</p>\n\n<p>Looking ahead, Oscar Health's full-year 2025 revenue guidance of $11.2-11.3 billion fell short of the consensus estimate of $11.69 billion, raising concerns among investors about the company's growth prospects. The disappointing guidance overshadowed the company's forecast for a return to profitability in 2025, with expected earnings from operations between $225-275 million.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OSCR","symbol_name":"Oscar Health, Inc.","start_time":0,"source_url":"","article_id":"1176108189","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176108189","pubTimestamp":1738717682,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Oscar Health, Inc.  stock plummeted 15.77% in Tuesday's trading session after the health insurer reported worse-than-expected fourth quarter earnings results and provided underwhelming full-year 2025 revenue guidance.For the fourth quarter of 2024, Oscar Health posted an earnings per share loss of $0.62, wider than the consensus analyst estimate of $0.58 per share. The company's revenue for the quarter came in at $2.39 billion, missing expectations of $2.47 billion. Higher medical costs were cit","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OSCR":"Oscar Health, Inc."},"translate_title":"Oscar Health股价暴跌15.77%，第四季度盈利未达预期，2025财年收入指引令人失望","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OSCR":1},"content_text":"Oscar Health, Inc. (OSCR) stock plummeted 15.77% in Tuesday's trading session after the health insurer reported worse-than-expected fourth quarter earnings results and provided underwhelming full-year 2025 revenue guidance.\nFor the fourth quarter of 2024, Oscar Health posted an earnings per share loss of $0.62, wider than the consensus analyst estimate of $0.58 per share. The company's revenue for the quarter came in at $2.39 billion, missing expectations of $2.47 billion. Higher medical costs were cited as a key factor behind the earnings miss.\nLooking ahead, Oscar Health's full-year 2025 revenue guidance of $11.2-11.3 billion fell short of the consensus estimate of $11.69 billion, raising concerns among investors about the company's growth prospects. The disappointing guidance overshadowed the company's forecast for a return to profitability in 2025, with expected earnings from operations between $225-275 million.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}